Nozinan injection 25mg/mL

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

levomepromazine, Quantity: 25 mg

Available from:

Sanofi-Aventis Australia Pty Ltd

INN (International Name):

Methotrimeprazine

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: water for injections; sodium sulfite; sodium chloride; ascorbic acid

Administration route:

Intravenous, Subcutaneous, Intramuscular

Units in package:

10 x 1mL

Class:

Medicine Listed (Export Only)

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

Nozinan Injection is indicated in the management of terminal pain and accompanying restlessness or distress.

Product summary:

Visual Identification: Clear bright colourless solution; Container Type: Ampoule; Container Life Time: 60 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Licence status A

Authorization date:

2009-07-06